SEHK:6996Pharmaceuticals
Antengene (SEHK:6996) Stock Drops As Profit Arrives And Valuation Looms
The market has spent the past week marking Antengene lower, with the stock down about 10% over seven days, yet the latest numbers tell a very different story. H1 2026 landed with a sharp swing into profit, with basic earnings per share at ¥0.34 and net income of ¥216.345 million on revenue of ¥513.076 million. For a high P/E stock trading at about 42.4x trailing earnings, this move into the black is the headline. The key question now is whether this profitability burst can justify that...